Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organigram Global Inc. - Common Shares (NQ:OGI)

0.9506 -0.0301 (-3.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Organigram Global Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Marijuana Stock Movers For April 4, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation. 
Via Benzinga
Topics Government
Exposures Political
Cannabis Stock Movers For April 3, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
OrganiGram Holdings Earnings Review: Q4 Summary
Via Benzinga
This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More
Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence
British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
OrganiGram Holdings Q4 Earnings Assessment
Via Benzinga
Organigram (OGI) Q1 2025 Earnings Call Transcript
OGI earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years
Organigram's Q1 FY25 sales hit C$66.8M. Net revenue rose 17%, and adjusted EBITDA improved to C$1.4M. Cash position set to reach C$113M. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For February 11, 2025
Via Benzinga
Organigram (OGI) Q4 2024 Earnings Call Transcript
OGI earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars
Organigram's Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For December 18, 2024
Via Benzinga
Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has announced the acquisition of 100% of Motif Labs Ltd. for CA$90 million ($64 million), comprising of CA$50 million in cash and CA$40 million in... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Rally: Canopy, Aurora, SNDL, OrganiGram And Others See Gains
Cannabis stocks rally as Canopy Growth, Aurora Cannabis, SNDL, and OrganiGram show positive momentum. We look at resistance levels... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
How Germany's Cannabis Market Is Dominating Europe And Unlocking New Profit Opportunities
Experts from the Benzinga Cannabis Capital Conference examined the profitability and growth prospects across global marijuana markets. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For September 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For September 20, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Our Conservative Cannabis Stock Portfolio Continues To Outperform
Our Conservative Cannabis Stocks Portfolio has outperformed our Canadian Cannabis LP Stocks Portfolio by more than a 3 to 1 margin on an annual basis. As such, our conservative cannabis portfolio is... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis LP Stocks Were +6% Last Week Vs. -10% The Previous Week
The Canadian Cannabis LP Stocks Portfolio was up +6% last week from a 10% decline w/e Sept. 6th as the negative sentiment waned surrounding the DEA's announcement that it would be having a December 2nd... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.